Viewing StudyNCT00004067



Ignite Creation Date: 2024-05-05 @ 11:20 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004067
Status: COMPLETED
Last Update Posted: 2021-04-29
First Post: 1999-12-10

Brief Title: Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
Sponsor: NSABP Foundation Inc
Organization: NSABP Foundation Inc

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
stage IIIA breast cancer View
stage II breast cancer View